Skip to content
Menu
Find Partners
Ion Channel World Map
Companies
Labs
Nonprofits
Resources
Ion Channel Overview
Fundamentals
Ion Channel Drugs
Interviews
Analytics
Expert opinions
Books
Infographics
Journal Covers
Quotes
External Resources
Blog
Menu
Find Partners
Ion Channel World Map
Companies
Labs
Nonprofits
Resources
Ion Channel Overview
Fundamentals
Ion Channel Drugs
Interviews
Analytics
Expert opinions
Books
Infographics
Journal Covers
Quotes
External Resources
Blog
Industry
-
26/02/2022
Biohaven Acquires Kv7 Ion Channel Platform for the Treatment of Epilepsy and Other Neurologic Disorders From Channel Biosciences, a Subsidiary of Knopp Biosciences
Source: PR Newswire
Industry
-
12/12/2020
QurAlis’ selective KCNQ2/3 opener, QRA-244, demonstrates up to 20-fold increase in potency and dramatic reduction in side effects compared to retigabine
